Michael Kaiser

Dr. Michael Kaiser


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Skin Appendage Disorders
Verified
Journal Article
Open access
PDF file
MKMichael Kaiser
Michael Kaiser
SAStephanie M. Almeida
Stephanie M. Almeida
MRMario Rodriguez
Mario Rodriguez
NINajy Issa
Najy Issa
NINaiem Tony Issa
Naiem Tony Issa
JJJoaquín J. Jiménez
Joaquín J. Jiménez
Introduction: We analyzed randomized clinical trials (RCTs) evaluating the efficacy of combined therapy with low-level light therapy (LLLT) and topical minoxidil for treatment of androgenetic alopecia (AGA). Methods: A literature search within PubMed identified RCTs evaluating hair regrowth following LLLT and minoxidil. Selection criteria were 600–1,100 nm wavelengths, treatment time ≥16 weeks, and objective evaluation for hair regrowth. Results: Five RCTs compared LLLT with minoxidil (2% or 5%) to 5% minoxidil treatment or LLLT treatment. One study showed combination therapy of LLLT, and 5% minoxidil improved hair density more than monotherapy. Another found combination LLLT with 2% minoxidil induced hair regrowth equivalent to 5% minoxidil. Similarly, another study described LLLT with 5% minoxidil versus minoxidil monotherapy to increase the number of hairs with no statistical difference between groups. One trial found that combination group increased hair regrowth in the first 2 months. The last study found a statistically significant increase in hair density with combined therapy compared to monotherapy. Conclusion: The studies describe either superiority or equivalence of combination therapy to minoxidil monotherapy for AGA. Early outcomes appear to support the superiority of combination therapy, but this advantage wanes at the end of the study periods.

Verified
Journal Article
Open access
PDF file
MKMichael Kaiser
Michael Kaiser
RARama Abdin
Rama Abdin
MYMarita Yaghi
Marita Yaghi
SGSimonetta Ines Gaumond
Simonetta Ines Gaumond
JJJoaquín J. Jiménez
Joaquín J. Jiménez
NINaiem T. Issa
Naiem T. Issa
Facial hair is an important social and psychologic aspect of clinical appearance for men. The purpose of this review is to provide a comprehensive overview of the causes of alopecia of the beard including the prevalence, pathophysiology, clinical presentation, and treatment. In this review, we highlight more common causes of beard alopecia including alopecia areata and pseudofolliculitis barbae, infectious causes such as tinea barbae and herpes simplex folliculitis, and rare causes including dermatopathia pigmentosa reticularis and frontal fibrosing alopecia. This review serves as an important resource for clinicians when faced with patients suffering from beard alopecia.

14 November 2024
Verified
Book Chapter
Closed access
PDF file
MKMichael Kaiser
Michael Kaiser
EBEvangelos V. Badiavas
Evangelos V. Badiavas

23 September 2022
Verified
Conference Paper
Closed access
MKMichael Kaiser
Michael Kaiser
NINaiem Issa
Naiem Issa
NINajy Issa
Najy Issa
LFLina M Ferrari
Lina M Ferrari
JJJoaquín J. Jiménez
Joaquín J. Jiménez
Androgenetic Alopecia (AGA) is the most common cause of alopecia in males and females. Minoxidil and finasteride are the only FDA approved treatm | POSTER

7 May 2023
Verified
Conference Paper
Closed access
MKMichael Kaiser
Michael Kaiser
NINaiem Issa
Naiem Issa
Cryotherapy has recently been examined as a potential treatment for Alopecia Areata (AA). AA can be managed with intralesional or systemic steroi | POSTER